Results of Single-Arm, Phase 1b Study of Anti-C1q Treatment (ANX009) Show that the Classical Pathway Is a Key Driver of Complement Activation and Consumption in Patients with Active Lupus Nephritis: SA-PO878

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2023-11, Vol.34 (11S), p.971-972
Main Authors: Bao, Min, Lichauco, Juan, Chen, Hsiang, Gomez, Harold, Tee, Michael L., Arroyo, Caroline, Lan, Joung-Liang, Fang, Yao-Fan, Chang, Edmund, Yousefpour, Noosha, Low, Julian, Chang, Qing, Osterloh, Jeannette, Manser, Paul, Mongan, Ann, Yednock, Ted, Artis, Dean R., Kroon, Henk-Andre, Andrews-Zwilling, Yaisa, Dall'Era, Maria
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1046-6673
DOI:10.1681/ASN.20233411S1971d